Centene / Ambetter denied your medication and prescription? Here is what to do next
Drug denials happen at the pharmacy benefit (PBM) layer, separate from the medical benefit. This guide is specific to Centene / Ambetter appeals.
If Centene / Ambetter denied your medication and prescription, you can appeal, and the plan must give you its file and the criteria it used. Filing windows by plan type: at least 180 days (insured and Marketplace plans); 60 days from the notice (Medicaid managed care); 65 days from the notice (Medicare Advantage). The date printed on your denial notice controls; it can only be later than these floors, never earlier.
Why Centene / Ambetter denies medication and prescription
Centene operates one of the largest Medicaid footprints in the U.S. and sells ACA marketplace coverage under the Ambetter brand. Marketplace plans drew elevated regulator and journalist scrutiny in 2024 for higher-than-average denial rates on in-network claims, and Centene-managed Medicaid lines vary plan-by-plan by state.
For medication and prescription specifically: Drug denials happen at the pharmacy benefit (PBM) layer, separate from the medical benefit. They include non-formulary drugs, GLP-1s, specialty injectables, brand-name vs. generic, and prior-auth-required medications.
Formulary tiering and exception rights, including the standard and expedited exception process ACA plans must offer under 45 C.F.R. § 156.122.
Centene / Ambetter appeals: the rule, the deadline and the next level, by plan type
Which row applies depends on the plan you hold, not on Centene / Ambetter's brand. Your ID card, the Summary Plan Description and the denial letter say which.
| Plan type | Rule that governs | File your appeal within | The plan must answer | If the plan says no again |
|---|---|---|---|---|
| Fully insured employer, individual or Marketplace plan The carrier holds the risk and is licensed in your state. Small employers and almost all individual and HealthCare.gov plans. | 45 CFR 147.136 (Public Health Service Act § 2719), which applies the 29 CFR 2560.503-1 procedures and adds state external review; state insurance law on top. | At least 180 days from the denial (45 CFR 147.136(b); 29 CFR 2560.503-1(h)(3)(i)). | Urgent care: 72 hours. Pre-service: 30 days. Post-service: 60 days. Prior-authorization decisions by Marketplace issuers from 2026: 72 hours expedited, 7 calendar days standard (CMS-0057-F). | External review through your state's process, or the federal process where the state has none, generally within 4 months of the final internal denial (45 CFR 147.136(c), (d)). The state insurance department and its Consumer Assistance Program take complaints. |
| Medicaid managed care plan A Medicaid plan run by the carrier under a state contract. The card says Medicaid, Medi-Cal, STAR, HealthChoice or your state's programme name. | 42 CFR Part 438, Subpart F (plan appeals) and 42 CFR Part 431, Subpart E (state fair hearings). | 60 calendar days from the date on the notice of adverse benefit determination to request the plan's appeal (42 CFR 438.402(c)(2)(ii)). State fair hearing: within 120 calendar days of the plan's appeal decision (§ 438.408(f)(2)). | Standard appeal: 30 calendar days. Expedited: 72 hours (42 CFR 438.408(b)). | A state fair hearing after the plan's single level of appeal (§ 438.402(b)); some states add an external medical review. Benefits continue during the appeal if you ask within 10 calendar days of the notice (§ 438.420). |
| Medicare Advantage (Part C) A private plan that replaces Original Medicare. The card says Medicare Advantage, HMO, PPO or PFFS. | 42 CFR Part 422, Subpart M (§§ 422.560 to 422.634). Coverage decisions must follow Original Medicare rules (42 CFR 422.101). | 65 calendar days from the date on the denial notice to request the plan's reconsideration (42 CFR 422.582, as amended effective 1 January 2025). | Expedited: 72 hours. Standard pre-service: 30 days (7 days for Part B drugs). Payment: 60 days (42 CFR 422.590). | If the plan does not fully reverse itself it must send the case to the Independent Review Entity on its own (42 CFR 422.592); then an ALJ hearing when the amount in controversy meets the annual threshold, the Medicare Appeals Council and federal court. State external review does not apply. |
What you can demand. The plan must give you the claim file, the criteria it applied and any new evidence or rationale before the final decision, free of charge (45 CFR 147.136(b)(2)(ii)(C); 29 CFR 2560.503-1(h)(2)(iii)).
How to open the appeal. Cite 45 CFR 147.136 and 29 CFR 2560.503-1: request the claim file and the criteria, note the decision clocks, and name the state external-review right.
What you can demand. Free copies of the case file, medical records and the criteria used, before and during the appeal (42 CFR 438.406(b)(5)). Children under 21 have EPSDT rights to medically necessary care (42 U.S.C. 1396d(r)(5)).
How to open the appeal. Cite 42 CFR 438.402 and 438.406(b)(5): request the case file and the criteria, ask for continued benefits within 10 days, and reserve the state fair hearing.
What you can demand. The plan may not apply internal criteria that are more restrictive than Medicare's national and local coverage determinations, and must decide medical necessity on your individual circumstances (42 CFR 422.101(b), (c)). You can ask for the case file and the criteria used.
How to open the appeal. Cite 42 CFR 422.582 and 422.101(c): the plan must decide on your individual circumstances under Medicare coverage rules, and must forward an unfavorable reconsideration to the IRE itself.
In the CMS Transparency in Coverage data for plan year 2026 (2024 claims), the 27 Centene / Ambetter-family Marketplace issuer filings across 21 states reported in-network claim denial rates from 13.7% to 36.3% (median 18.8%). Issuer-level, self-reported, HealthCare.gov plans only; a denial includes duplicate and administrative denials.
Centene / Ambetter denial rate: every state, three years →Primary sources for this table
- 45 CFR 147.136, internal claims and appeals and external review
- 29 CFR 2560.503-1, ERISA claims procedure
- HealthCare.gov, how to appeal an insurance company decision
- CMS-0057-F, prior-authorization decision timeframes from 2026
- 42 CFR Part 438, Subpart F, Medicaid managed care grievance and appeal system
- 42 CFR Part 431, Subpart E, Medicaid fair hearings
- 42 CFR Part 422, Subpart M, Medicare Advantage grievances, organization determinations and appeals
- 42 CFR 422.101, Medicare Advantage coverage rules and medical-necessity decisions
- Medicare.gov, claims and appeals
Windows are federal floors or the rule as written; the denial notice controls. Reviewed 13 September 2026. General information, not legal advice; Apellica is not a law firm.
What Centene / Ambetter denies for medication and prescription
The medication and prescription services most often denied:
- GLP-1s (Ozempic, Wegovy, Mounjaro, Zepbound)
- Specialty biologics (Humira, Stelara, Dupixent)
- ADHD medications (Vyvanse, Adderall XR)
- Hepatitis C antivirals
- Hormone replacement therapy
- Compounded medications
- Off-label prescription uses
Why medication and prescription claims get denied
A typical Centene / Ambetter medication and prescription denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:
- Drug not on plan formulary (non-formulary)
- Step therapy: cheaper alternative not tried first
- Quantity limit exceeded
- Plan claims indication not FDA-approved
- Diagnosis ICD doesn't match approved indication
The Centene / Ambetter appeal process
Appeal levels: Marketplace: internal appeal then federal external review (IRO). Medicaid: plan appeal then state fair hearing. Medicare Advantage: federal 5-level ladder.
Carrier timing: 180 days from denial for marketplace internal appeals; 4 months / 120 days for federal external review. Medicaid fair-hearing deadlines vary by state, often as short as 90-120 days.
Medication timing: Urgent: 24-72 hours. Standard: 72 hours for Medicare Part D, 15 days for commercial. Filing window: typically 60 days.
What we know about Centene / Ambetter: We confirm the specific Centene subsidiary (Ambetter, Sunshine Health, Wellcare, etc.) before filing, because procedural rules and the supervising regulator change with the line of business.
Common Centene / Ambetter denial patterns for medication and prescription
- ACA marketplace in-network denials. Ambetter marketplace plans have been documented denying in-network medical claims at rates above the marketplace average. Federal ACA rules guarantee internal appeal plus external review via an Independent Review Organization (IRO), both are no-cost to the member.
- Narrow networks driving care-access denials. Ambetter HMO products often run narrower networks than the local competition. Network-adequacy challenges (state DOI complaints citing inadequate specialist access) can convert an out-of-network denial into in-network coverage.
- Medicaid managed care fair hearings. Centene-managed Medicaid plans (Sunshine Health, Buckeye, Peach State, etc.) operate under each state's Medicaid rules. After plan-level appeal, members have the right to a state fair hearing, a binding administrative process with strong reversal history.
How to win your Centene / Ambetter medication and prescription appeal
Strategy for medication and prescription: Two paths: (1) tiering exception, request that the drug be moved to a covered tier; (2) formulary exception, request coverage of a non-formulary drug citing medical necessity. Manufacturer-published clinical packets accelerate exception filings.
Filed against Centene / Ambetter, that strategy rides on this procedural spine:
- Procedural-rights anchor. Cite 45 CFR 147.136 and 29 CFR 2560.503-1: request the claim file and the criteria, note the decision clocks, and name the state external-review right. If your Centene / Ambetter coverage is a different plan type (Medicaid managed care plan, Medicare Advantage), use that row of the table above instead; the rule and the deadline change with the plan, not the carrier.
- Criteria-disclosure demand. Centene / Ambetter frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
- Controlling-standard citation. Formulary tiering and exception rights, including the standard and expedited exception process ACA plans must offer under 45 C.F.R. § 156.122.
- Treating-provider attestation. A letter from the treating physician addressing each criterion in Centene / Ambetter's own policy language. This is the single strongest evidentiary element.
- Requested action. A specific demand to reverse the medication and prescription denial and approve the service, not a general "please reconsider."
Documents you'll need for your Centene / Ambetter medication and prescription appeal
- Denial letter from pharmacy benefit
- Prescription / Rx record
- Prescriber's notes on indication
- Documentation of prior step-therapy trials
What a medication and prescription appeal can recover
Typical recovery for medication and prescription cases runs $200 - $20,000+ per month of medication. The exact figure depends on the specific service and your plan's contracted rates.
Centene / Ambetter medication and prescription appeals: frequently asked questions
Can I appeal your Centene / Ambetter prescription denial?
Yes. Drug denials happen at the pharmacy-benefit layer and have two appeal paths: a tiering exception to move a covered drug to a lower-cost tier, or a formulary exception to cover a non-formulary drug on medical-necessity grounds.
How fast is your Centene / Ambetter medication appeal decided?
Urgent requests are decided in 24 to 72 hours. Standard requests take 72 hours for Medicare Part D and up to 15 days for commercial plans. The filing window is typically 60 days.
Why was my drug denied as non-formulary or step therapy?
Plans deny when a drug is off-formulary, when a cheaper alternative has not been tried first (step therapy), when a quantity limit is exceeded, or when the diagnosis code does not match the approved indication. Manufacturer clinical packets accelerate exception filings.
What documents support your Centene / Ambetter medication exception?
The pharmacy-benefit denial letter, the prescription record, the prescriber's notes on the indication, and documentation of any prior step-therapy trials and their outcomes.
What Apellica does for Centene / Ambetter medication and prescription appeals
We file appeals against Centene / Ambetter specifically configured to its internal review process. Every medication and prescription appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.
Cost: $0 upfront. We work on contingency for Centene / Ambetter appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.
Start your Centene / Ambetter medication and prescription appeal
Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.
Start free appeal review →Questions people ask next
- My drug was denied as a formulary exclusion. How do I get an exception?
- Step therapy denied my drug. Can I appeal?
- How often are Wegovy or Zepbound denials overturned on appeal?
What to read next
- Your Drug Isn't on the Formulary: How to Win a Formulary Exception — the full guide to this kind of denial, for any insurer
- Medication and prescription appeal letter template — free, fill in your own details
- How medication and prescription denials are appealed
- Work out your own appeal deadline
Related Centene / Ambetter guides
- Centene / Ambetter surgery denials appeal guide
- Centene / Ambetter mri and imaging denials appeal guide
- Centene / Ambetter medicare denials appeal guide
- Centene / Ambetter prior authorization denials appeal guide